Pharma outsourcing recovering, but tough times are ahead

November 26, 2010
Manufacturing and Production, Research and Development AAPS, American Association of Pharmaceutical Sciences, Jim Miller, Pharmsource, contract manufacturing, contract research, pharma outsourcing

There are signs that outsourcing in the pharmaceutical sector is staging a comeback after a couple of tough operating years, …

Contract research news in brief

November 26, 2010
Research and Development Chemir Analytical Services, Convergence, Cyanta, ICON, Iris Pharma, PRA, Proteome Sciences, Selcia, chiltern, contract research

Our round-up of recent development in the contract research sector includes updates from Selcia, Iris Pharma, ICON, Proteome Sciences, Chiltern, …

abpi_sam_ogden

Roche’s Sam Ogden joins the ABPI

November 25, 2010
Medical Communications, Sales and Marketing ABPI, Sam Ogden, appointment, medical communications, sales and marketing

The ABPI has appointed Sam Ogden as membership engagement account director. She is currently head of in-field effectiveness at Roche …

European Parliament

Europe tightens patient information proposals

November 25, 2010
Medical Communications, Sales and Marketing European Commission, European Parliament, dtc, patient information

European restrictions on patient access to medicines information are still on track to be relaxed, but the proposed changes have …

Gilead’s pill shows promise in HIV prevention

November 25, 2010
Research and Development, Sales and Marketing AIDS, Bill and Melinda Gates Foundation, Gilead, HIV, UN, UNAIDS, emtricitabine, tenofovir

Gileadโ€™s HIV drug Truvada can help prevent men from contracting the disease through sexual intercourse, a new study shows.The clinical …

UN says Treatment 2.0 approach needed for AIDS

November 25, 2010
Research and Development, Sales and Marketing AIDS, HIV, UN, UNAIDS

A new report on the spread of AIDS has called for the development of new pharma compounds that will lead …

Tarceva tablet

Roche set to challenge NICE Tarceva decision

November 25, 2010
Sales and Marketing NICE, Roche, Roche UK, Tarceva, erlotinib, lung cancer

NICE has again rejected Rocheโ€™s lung cancer drug Tarceva in its second round of draft guidance. Tarceva (erlotinib) was being …

The renal cell carcinoma market: Votrient to challenge Sutentโ€™s lead

November 25, 2010
Sales and Marketing GSK, GlaxoSmithKline, Pfizer, Sutent, Votrient, rcc, renal cell carcinoma

After decades of no new medicines emerging to treat renal cell carcinoma, no fewer than five new drugs were approved …

Dr Reddy's Hyderabad, India

GSK sells antibiotics assets to Dr Reddyโ€™s

November 24, 2010
Manufacturing and Production, Sales and Marketing Antibiotics, Dr Reddy's, GSK

Dr. Reddyโ€™s Laboratories has bought a US oral penicillin facility from GSK, along with the US marketing rights to the …

Varnish chemical migrates into medicine bottles, says study

November 24, 2010
Manufacturing and Production AAPS, HDPE, chemical migration, varnish

A chemical found in the varnish coating of pharmaceutical bottles has been show to migrate into the contents and be …

Brain cancer vaccine to move into phase III

November 24, 2010
Research and Development, Sales and Marketing Celldex, Pfizer, brain cancer, glioblastoma

Celldex will press ahead with large-scale trials of its vaccine treatment for brain cancer after encouraging phase II results. The …

NICE recommends Herceptin for gastric cancer, blocks high dose Glivec

November 24, 2010
Sales and Marketing Cancer, GIST, Glivec, HER2, Herceptin, NICE, gastric cancer

NICE has recommended Rocheโ€™s cancer drug Herceptin for patients with HER2 metastatic gastric cancer. NICE was initially minded not to …

Healthcare, politics and the NHS

November 24, 2010
Research and Development Academy of Medical Sciences, Les Roes, NHS, clinical trials, clinical trials governance, evidence-based medicine

I have just participated in a consultation by the Academy of Medical Sciences on the regulation and governance of clinical …

Pharma manufacturing news in brief

November 23, 2010
Manufacturing and Production Alpah Biologics, Alpha Biologics, Kemwell, Lonza, Phil Taylor, Roche

Facility updates from Roche, Alpha Biologics, Kemwell and Reinnervate, new contract services from Lonza and Patheon, plus a milestone in …

brinsmeadweb

Brinsmead to be life sciences adviser to government

November 23, 2010
Sales and Marketing Brinsmead, NHS, government, life sciences

Chris Brinsmead, chairman of AstraZeneca UK, has been made the governmentโ€™s life sciences business adviser. He was appointed by universities …

Roche to develop diagnostic tools for Tarceva

November 23, 2010
Sales and Marketing Genzyme, NSCLC, Roche, Tarceva, diagnostic

Roche has obtained a worldwide sub-license from Genzyme to develop a diagnostic kit for the detection of specific mutations for …

Vytorin cuts heart problems in kidney patients

November 23, 2010
Sales and Marketing Merck, Vytorin, cardiovascular, simvastatin

Vytorin has been shown to reduce potentially heart problems in patients with chronic kidney disease (CKD) in a new study. …

Offshore outsourcing in Regulatory Affairs and Pharmacovigilance

November 22, 2010
Sales and Marketing Kinapse, White paper

Based on Kinapseโ€™s direct experience, we explore the emerging environment for regulatory and pharmacovigilance offshore outsourcing within the biopharmaceutical industry …

A new generation of analogues for valuing strategy

November 22, 2010
Sales and Marketing Alex Blyth, MSI, forecasting, marketing, marketing strategy

Anyone who is involved in the planning of pharma marketing campaigns will know that the Holy Grail is trying to …

synovate_chris_king

Chris King joins Synovate Healthcare

November 22, 2010
Sales and Marketing Chris King, Synovate Healthcare, appointment, sales and marketing

Synovate has appointed Chris King head of its European Oncology Monitor within its specialist healthcare research division. He joins the …

The Gateway to Local Adoption Series

Latest content